Euglycemia despite a sodium glucose co-transporter 2 inhibitor overdose  

作　　者：Muhammad Akbar Baig Joshua Nogar 

机构地区：[1]NorthShore University Health System,Manhasset,NY 11030,USA

出　　处：《World Journal of Emergency Medicine》2022年第2期147-148,共2页世界急诊医学杂志（英文）

摘　　要：Dear editor,Sodium glucose co-transporter 2 inhibitors(SGLT2I)reduce the majority of reabsorption of glucose in the proximal tubules,which reduces blood glucose levels by allowing excretion of excess glucose in the urine.[1]By inhibiting glucose reabsorption,they increase the osmotic pressure of urine resulting in diuresis which can cause a reduction of blood pressure.[2]Fortunately,as these drugs are not directly implicated in altering glucose metabolism or causing insulin secretion,SGLT2I monotherapy does not result in severe hypoglycemia.

关 键 词：URINE METABOLISM DRUGS 

分 类 号：R595.4[医药卫生—内科学]